Browsing Tag
Achin Gupta
4 posts
Cipla Limited (NSE: CIPLA) secures FDA approval for generic nintedanib capsules, entering a $3.8bn U.S. pulmonary fibrosis market
Cipla wins FDA approval for generic nintedanib capsules for IPF, targeting Boehringer Ingelheim's $3.76B Ofev market. Here's what the launch means for investors. Read more.
Cipla launches Cippoint point-of-care testing device in India
Indian pharma company Cipla Limited has launched a point-of-care testing device called Cippoint in India for infectious diseases,…
Cipla to acquire 21% stake in medical test kits provider Achira Labs
Cipla Limited has agreed to acquire a stake of 21.05% in Achira Labs, a provider of point of…
Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment
Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler…